Relative Strength Chart Genscript Biotech Corporation
Stocks
1548
KYG3825B1059
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.22 HKD | -8.76% |
|
-4.48% | +6.44% |
| 07-16 | Genscript Associate Reports $657 Million in Carvykti Sales Under License Agreement | MT |
| 06-15 | Genscript Associate Reports Promising Phase 1 Data for LB2501 in B-Cell Lymphoma | MT |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GENSCRIPT BIOTECH CORPORATION | Other Biotechnology & Medical Research | -8.76% | -4.48% | +6.44% | -20.55% | -68.49% | 4.05B |  |  | |
- Stock Market
- Stocks
- 1548 Stock
- Charts Genscript Biotech Corporation
- Relative Strength Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition